Richardet, Martin

Instituto Oncológico de Córdoba

2 papers on CoChat

Most cited papers

Verified
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Choueiri, T. K., Powles, T., Burotto, M., Escudier, B., Bourlon, M. T., Zurawski, B., Oyervides Juárez, V. M., Hsieh, J. J., Basso, U., Shah, A. Y., et al. (2021) · New England Journal of Medicine
Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers
Cited by 1,791
Verified
Subcutaneous versus intravenous nivolumab for renal cell carcinoma
Albiges, L., Bourlon, M. T., Chacón, M., Cutuli, H. J., Chuken, Y. A. L., Żurawski, B., Mota, J. M., Magri, I., Burotto, M., Luz, M., et al. (2025) · Annals of Oncology
Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers
Cited by 31

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free